GlassScriptPhysician profile
Micah Benjamin Naimark
NPI 1811263635
$8,756.70
in general payments reported to CMS, 2019-2025
12 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,949 · 2020: $1,723 · 2021: $2,505 · 2022: $1,237 · 2023: $546 · 2024: $415 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $3,853.86 | 2019-2022 | |
| Arthrex, INC. | $1,888.45 | 2021 | |
| Wright Medical Technology, INC. | $1,431.79 | 2019-2020 | |
| Stryker Corporation | $1,092.36 | 2021-2025 | Blueprint Patient Specific Instrumentation, Iconix, Alphavent |
| Depuy Synthes Sales INC. | $169.92 | 2019-2025 | Dynacord, Healix Knotless Peek, Motoband |
| Smith+Nephew, INC. | $127.82 | 2023 | Na |
| Medical Device Business Services, INC. | $77.23 | 2024 | |
| Nevro Corp. | $48.29 | 2019 | |
| Abbott Laboratories | $22.15 | 2022 | |
| Pacira Therapeutics, INC. | $16.92 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.57 | 2022 | |
| Merz North America, INC. | $13.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Naimark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.